We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$771M
AUM Growth
+$32.5M
Cap. Flow
+$15.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
16.24%
Holding
916
New
72
Increased
419
Reduced
247
Closed
78

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.52M
2
VST icon
Vistra
VST
+$1.08M
3
ETP
Energy Transfer Partners, L.P.
ETP
+$1,000K
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$971K
5
AAPL icon
Apple
AAPL
+$804K

Top Sells

Rank Stock Value
1
TRR
Trc Companies
TRR
+$9.24M
2
GGP
GGP Inc.
GGP
+$1.5M
3
CNA icon
CNA Financial
CNA
+$1.04M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$779K
5
CVS icon
CVS Health
CVS
+$759K

Sector Composition

Rank Sector Weight
1 Financials 10.7%
2 Healthcare 10.11%
3 Consumer Discretionary 9.02%
4 Technology 8.48%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BP icon
76
BP
BP
$113B
$1.95M 0.25%
63,412
+303
+0.5% +$9.43K
MMM icon
77
3M
MMM
$89B
$1.93M 0.25%
11,083
+995
+10% +$166K
EHI
78
Western Asset Global High Income Fund
EHI
$175M
$1.9M 0.25%
189,157
+16,595
+10% +$169K
UMH
79
UMH Properties
UMH
$1.32B
$1.87M 0.24%
109,487
+13,565
+14% +$224K
USA icon
80
Liberty All-Star Equity Fund
USA
$1.75B
$1.84M 0.24%
325,116
+30,744
+10% +$171K
GM icon
81
General Motors
GM
$74.7B
$1.84M 0.24%
52,598
+5,851
+13% +$199K
GSK icon
82
GSK
GSK
$103B
$1.8M 0.23%
33,326
+7,879
+31% +$420K
ISRG icon
83
Intuitive Surgical
ISRG
$121B
$1.75M 0.23%
16,839
+171
+1% +$16.4K
ORCL icon
84
Oracle
ORCL
$331B
$1.75M 0.23%
34,816
+1,641
+5% +$74.8K
GAB icon
85
Gabelli Equity Trust
GAB
$1.74B
$1.74M 0.23%
290,042
+3,899
+1% +$23.1K
QQQ icon
86
Invesco QQQ Trust
QQQ
$455B
$1.74M 0.23%
12,629
+1,174
+10% +$161K
LULU icon
87
lululemon athletica
LULU
$13B
$1.71M 0.22%
28,638
-1,260
-4% -$65.6K
RDS.A
88
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.68M 0.22%
31,652
+1,896
+6% +$102K
BOND icon
89
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.28B
$1.66M 0.22%
15,652
-3,201
-17% -$339K
EEI
90
DELISTED
Ecology and Environment
EEI
$1.66M 0.22%
132,207
-7,058
-5% -$79.8K
FAM
91
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$1.64M 0.21%
140,936
+18,367
+15% +$218K
CRM icon
92
Salesforce
CRM
$134B
$1.64M 0.21%
18,949
+3,059
+19% +$266K
EMD
93
Western Asset Emerging Markets Debt Fund
EMD
$609M
$1.63M 0.21%
104,346
+4,932
+5% +$77.5K
NVO
94
Novo Nordisk
NVO
$216B
$1.61M 0.21%
+75,326
New +$1.52M
NVS icon
95
Novartis
NVS
$295B
$1.61M 0.21%
21,528
-2,434
-10% -$173K
LQD icon
96
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$1.61M 0.21%
13,343
-2,871
-18% -$343K
BTZ icon
97
BlackRock Credit Allocation Income Trust
BTZ
$927M
$1.6M 0.21%
119,253
+5,065
+4% +$67.7K
CL icon
98
Colgate-Palmolive
CL
$72.6B
$1.56M 0.2%
21,062
+1,431
+7% +$106K
FOF icon
99
Cohen & Steers Closed End Opportunity Fund
FOF
$374M
$1.53M 0.2%
117,756
-4,939
-4% -$63.7K
GLD icon
100
SPDR Gold Trust
GLD
$131B
$1.5M 0.2%
12,754
+2,306
+22% +$276K
2 3
4
5 6

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Wedbush Securities held 916 positions worth $771M, up 4.4% from $738M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q2 2017 filing shows 72 new, 419 increased, 247 reduced and 78 closed positions. Its largest new stake was Novo Nordisk: 75,326 shares worth $1.61M. The largest sale was Trc Companies, an estimated $9.24M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Wedbush Securities's largest Q2 2017 buy was Novo Nordisk: 75,326 shares worth $1.61M.
  • Wedbush Securities added most to Apple in Q2 2017, an estimated $804K increase.
  • Wedbush Securities's biggest Q2 2017 reduction was GGP Inc., cutting an estimated $1.5M.
  • Wedbush Securities fully exited Trc Companies in Q2 2017, selling an estimated $9.24M.
  • Wedbush Securities's ten largest holdings make up 16% of its $771M portfolio in Q2 2017.
  • Wedbush Securities opened 72 new positions and closed 78 in Q2 2017.
  • Wedbush Securities's portfolio value rose 4.4% quarter-over-quarter to $771M.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.